---
figid: PMC5385394__WJG-23-2276-g001
figlink: /pmc/articles/PMC5385394/figure/F1/
number: F1
caption: Schematic of major pathways associated with pancreatic ductal adenocarcinoma
  and site of action of current treatments. Multiple pathways and receptors are associated
  with the development of pancreatic ductal adenocarcinoma (PDAC) including epidermal
  growth factor receptors (EGFR), human epidermal growth factor receptor 2 (Her2),
  and vascular endothelial growth factor receptor (VEGFR). All of these have important
  roles in the RAS/RAF/MEK/ERK and AKT/PI3K/mTOR pathways involved in cell growth.
  EGFR also has a role in the JAK/STAT pathway necessary for activation of signalling
  cascades and gene transcription. Transforming growth factor (TGF-β) is a multifunctional
  cytokine involved in various processes some of which are mediated by SMAD 4, a known
  mutation associated with development of PDAC. Current therapeutics target these
  processes at various sites.
pmcid: PMC5385394
papertitle: Advanced pancreatic ductal adenocarcinoma - Complexities of treatment
  and emerging therapeutic options.
reftext: Chandra Diwakarla, et al. World J Gastroenterol. 2017 Apr 7;23(13):2276-2285.
pmc_ranked_result_index: '112221'
pathway_score: 0.8098995
filename: WJG-23-2276-g001.jpg
figtitle: Major pathways associated with pancreatic ductal adenocarcinoma and site
  of action of current treatments
year: '2017'
organisms: Homo sapiens
ndex: b25bab40-df24-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5385394__WJG-23-2276-g001.html
  '@type': Dataset
  description: Schematic of major pathways associated with pancreatic ductal adenocarcinoma
    and site of action of current treatments. Multiple pathways and receptors are
    associated with the development of pancreatic ductal adenocarcinoma (PDAC) including
    epidermal growth factor receptors (EGFR), human epidermal growth factor receptor
    2 (Her2), and vascular endothelial growth factor receptor (VEGFR). All of these
    have important roles in the RAS/RAF/MEK/ERK and AKT/PI3K/mTOR pathways involved
    in cell growth. EGFR also has a role in the JAK/STAT pathway necessary for activation
    of signalling cascades and gene transcription. Transforming growth factor (TGF-β)
    is a multifunctional cytokine involved in various processes some of which are
    mediated by SMAD 4, a known mutation associated with development of PDAC. Current
    therapeutics target these processes at various sites.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - KRAS
  - JAK3
  - TGFB2
  - STAT4
  - STAT5A
  - TGFB1
  - STAT3
  - MAP2K1
  - MAP2K2
  - STAT5B
  - STAT6
  - ERBB2
  - SMAD4
  - JAK2
  - JAK1
  - STAT1
  - FLT1
  - EGFR
  - MAPK1
  - MAPK3
  - KDR
  - NRAS
  - BRAF
  - STAT2
  - TGFB3
  - ARAF
  - RAF1
  - TYK2
  - FLT4
  - HRAS
  - Gemcitabine
  - Taxanes
  - paclitaxel
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: RAS/RAF/MEK/ERK
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: TGFB
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: TGFB
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: RAS/RAF/MEK/ERK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: RAS/RAF/MEK/ERK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: Her2
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: SMAD4
  symbol: SMAD4
  source: hgnc_symbol
  hgnc_symbol: SMAD4
  entrez: '4089'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT1
  entrez: '2321'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: RAS/RAF/MEK/ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: RAS/RAF/MEK/ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: RAS/RAF/MEK/ERK
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RAS/RAF/MEK/ERK
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: TGFB
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: RAS/RAF/MEK/ERK
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAS/RAF/MEK/ERK
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT4
  entrez: '2324'
- word: RAS/RAF/MEK/ERK
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
chemicals:
- word: Gemcitabine
  source: MESH
  identifier: C056507
- word: Taxanes
  source: MESH
  identifier: C080625
- word: paclitaxel
  source: MESH
  identifier: D017239
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC5385394__F1
redirect_from: /figures/PMC5385394__F1
figtype: Figure
---
